ClearPoint Neuro, Inc.
CLPT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $337,404 | $329,578 | $415,686 |
| - Cash | $38,221 | $41,541 | $12,387 | $20,104 |
| + Debt | $35,398 | $6,611 | $3,438 | $3,568 |
| Enterprise Value | – | $302,474 | $320,629 | $399,150 |
| Revenue | $8,861 | $9,215 | $8,485 | $7,771 |
| % Growth | -3.8% | 8.6% | 9.2% | – |
| Gross Profit | $5,600 | $5,556 | $5,132 | $4,762 |
| % Margin | 63.2% | 60.3% | 60.5% | 61.3% |
| EBITDA | -$5,274 | -$5,106 | -$5,829 | -$5,133 |
| % Margin | -59.5% | -55.4% | -68.7% | -66.1% |
| Net Income | -$5,891 | -$5,837 | -$6,026 | -$5,386 |
| % Margin | -66.5% | -63.3% | -71% | -69.3% |
| EPS Diluted | -0.21 | -0.21 | -0.22 | -0.2 |
| % Growth | 0% | 4.5% | -10% | – |
| Operating Cash Flow | -$3,121 | -$2,552 | -$6,172 | -$1,243 |
| Capital Expenditures | -$199 | -$91 | -$183 | -$263 |
| Free Cash Flow | -$3,320 | -$2,643 | -$6,355 | -$1,506 |